Risedronate rapidly reduces vertebral fracture risk in postmenopausal women with established osteoporosis

被引：0
|
作者：
Roux, C
Miller, P
Gennari, C
Keller, M
Sorensen, O
Ritter-Hrncirik, C
Barton, I
Watts, N
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1300
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [41] Risedronate reduces the risk of first vertebral fracture in osteoporotic women as soon as 1 year.
    Geusens, P
    Heaney, R
    Chesnut, C
    Cros, M
    Bos, K
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S37 - S37
  • [42] Risedronate reduces the risk of non-vertebral fractures in osteoporotic postmenopausal women as soon as 6 months
    Boonen, S
    Brandi, ML
    Harrington, T
    Barton, I
    Ste-Marie, LG
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S15 - S16
  • [43] Monofluorophosphate combined with calcium and hormone replacement therapy reduces risk of vertebral fractures in established postmenopausal osteoporosis
    Ringe, JD
    Setnikar, I
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S43
  • [44] Risedronate reduces hip fracture risk in elderly women with osteoporosis with a rapid and sustained effect.
    Silverman, S
    Geusens, P
    Bensen, W
    Benhamou, L
    Fogelman, I
    Zorich, N
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S197 - S197
  • [45] Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
    Lindsay, R
    Scheele, WH
    Neer, R
    Pohl, G
    Adami, S
    Mautalen, C
    Reginster, JY
    Stepan, JJ
    Myers, SL
    Mitlak, BH
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) : 2024 - 2030
  • [46] Raloxifene and risk of vertebral fracture in postmenopausal women
    Halbekath, J
    Becker-Brüser, W
    Wille, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17): : 2236 - 2236
  • [47] Risedronate prevents new vertebral fractures in postmenopausal women at high risk
    Watts, NB
    Josse, RG
    Hamdy, RC
    Hughes, RA
    Manhart, MD
    Barton, I
    Calligeros, D
    Felsenberg, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 542 - 549
  • [48] Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture
    Reginster, JY
    Rizzoli, R
    Balogh, A
    Badurski, J
    Spector, T
    Tulassay, Z
    Felsenberg, D
    Cannata, JB
    Phenekos, C
    Ortolani, S
    Meunier, PJ
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S113 - S113
  • [49] Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women without prevalent vertebral fracture
    Reginster, JY
    Balogh, A
    Badurski, J
    Spector, TD
    Pors-Nielsen, S
    Felsenberg, D
    Cannata, JB
    Phenekos, C
    Rizzoli, R
    Ortolani, S
    Seeman, E
    Meunier, PJ
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S7 - S8
  • [50] STRONTIUM RANELATE REDUCES THE RISK OF VERTEBRAL FRACTURES IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN WITHOUT PREVALENT VERTEBRAL FRACTURE
    Reginster, J.
    Rizzoli, R.
    Balogh, A.
    Badurski, J.
    Spector, T.
    Tulassay, Z.
    Felsenberg, D.
    Cannata, J. B.
    Phenekos, C.
    Ortolani, S.
    Meunier, P. J.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S83 - S83
12345